JP Morgan Chase’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$102M Sell
1,158,837
-24,574
-2% -$2.08M 0.01% 1060
2026
Q1
$96.4M Buy
1,183,411
+18,100
+2% +$1.49M 0.01% 1007
2025
Q4
$107M Sell
1,165,311
-39,766
-3% -$3.81M 0.01% 913
2025
Q3
$114M Buy
1,205,077
+124,283
+11% +$11.7M 0.01% 929
2025
Q2
$113M Buy
1,080,794
+176,435
+20% +$16.7M 0.01% 888
2025
Q1
$79.9M Sell
904,359
-167,907
-16% -$17.2M 0.01% 1052
2024
Q4
$103M Sell
1,072,266
-143,055
-12% -$13.3M 0.01% 920
2024
Q3
$99.5M Sell
1,215,321
-252,244
-17% -$19.5M 0.01% 956
2024
Q2
$127M Sell
1,467,565
-68,893
-4% -$5.57M 0.01% 815
2024
Q1
$125M Sell
1,536,458
-555,490
-27% -$43.4M 0.01% 838
2023
Q4
$139M Sell
2,091,948
-239,157
-10% -$16.6M 0.01% 750
2023
Q3
$170M Sell
2,331,105
-182,914
-7% -$12.4M 0.02% 601
2023
Q2
$159M Buy
2,514,019
+39,589
+2% +$2.3M 0.02% 632
2023
Q1
$145M Buy
2,474,430
+331,735
+15% +$20.1M 0.02% 653
2022
Q4
$132M Sell
2,142,695
-8,515
-0.4% -$572K 0.02% 662
2022
Q3
$144M Sell
2,151,210
-305,801
-12% -$19.4M 0.02% 590
2022
Q2
$151M Sell
2,457,011
-212,694
-8% -$13.6M 0.02% 600
2022
Q1
$180M Buy
2,669,705
+81,859
+3% +$4.42M 0.02% 596
2021
Q4
$114M Buy
2,587,846
+589,509
+29% +$34.3M 0.01% 825
2021
Q3
$129M Buy
1,998,337
+27,078
+1% +$1.88M 0.02% 747
2021
Q2
$159M Sell
1,971,259
-44,744
-2% -$3.41M 0.02% 685
2021
Q1
$137M Sell
2,016,003
-64,011
-3% -$5.03M 0.02% 712
2020
Q4
$145M Buy
2,080,014
+169,805
+9% +$10.6M 0.02% 637
2020
Q3
$94.5M Buy
1,910,209
+580,416
+44% +$31.9M 0.02% 718
2020
Q2
$78M Buy
1,329,793
+76,331
+6% +$4.22M 0.02% 732
2020
Q1
$63.4M Buy
1,253,462
+210,068
+20% +$13.9M 0.01% 719
2019
Q4
$77.3M Buy
1,043,394
+31,254
+3% +$1.95M 0.01% 767
2019
Q3
$57.8M Buy
1,012,140
+106,966
+12% +$7.1M 0.01% 878
2019
Q2
$59.1M Buy
905,174
+90,605
+11% +$6.31M 0.01% 886
2019
Q1
$60.3M Sell
814,569
-55,785
-6% -$3.92M 0.01% 874
2018
Q4
$51.9M Sell
870,354
-135,317
-13% -$10.9M 0.01% 879
2018
Q3
$94.9M Sell
1,005,671
-65,874
-6% -$5.67M 0.02% 716
2018
Q2
$80.5M Sell
1,071,545
-157,566
-13% -$11.3M 0.02% 732
2018
Q1
$74.4M Buy
1,229,111
+78,021
+7% +$4.22M 0.02% 754
2017
Q4
$53.7M Buy
1,151,090
+158,271
+16% +$7.84M 0.01% 947
2017
Q3
$49.4M Buy
992,819
+31,147
+3% +$1.45M 0.01% 936
2017
Q2
$47.9M Buy
961,672
+87,609
+10% +$4.1M 0.01% 927
2017
Q1
$37.1M Sell
874,063
-93,181
-10% -$4.12M 0.01% 1087
2016
Q4
$39.2M Buy
967,244
+291,695
+43% +$11.3M 0.01% 1044
2016
Q3
$25.6M Buy
675,549
+182,935
+37% +$5.8M 0.01% 1220
2016
Q2
$15M Buy
492,614
+2,400
+0.5% +$63K ﹤0.01% 1592
2016
Q1
$12.1M Buy
490,214
+70,607
+17% +$1.51M ﹤0.01% 1665
2015
Q4
$10.5M Buy
419,607
+71,932
+21% +$2.21M ﹤0.01% 1786
2015
Q3
$10.3M Buy
347,675
+10,900
+3% +$343K ﹤0.01% 1744
2015
Q2
$10.8M Hold
336,775
﹤0.01% 1880
2015
Q1
$8.41M Buy
336,775
+12,054
+4% +$261K ﹤0.01% 2014
2014
Q4
$8.26M Buy
324,721
+11,096
+4% +$241K ﹤0.01% 2074
2014
Q3
$5.74M Buy
+313,625
New +$6.02M ﹤0.01% 2276

Other funds holding HQY

JP Morgan Chase's HQY Position: Q2 2026 in Review

JP Morgan Chase reduced its HealthEquity (HQY) stake by 2.1% in Q2 2026, selling an estimated $2.08M and leaving 1,158,837 shares worth $102M. The position accounts for 0.01% of the portfolio, ranked #1060.

JP Morgan Chase first reported a position in HQY in Q3 2014 and has held it in 48 quarters since. The position peaked at $180M in Q1 2022. 498 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • JP Morgan Chase held 1,158,837 shares of HealthEquity worth $102M as of Q2 2026.
  • JP Morgan Chase sold 24,574 HealthEquity shares in Q2 2026, an estimated $2.08M.
  • HealthEquity made up 0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1060 holding.
  • JP Morgan Chase first reported a position in HealthEquity in Q3 2014 and has held it in 48 quarters since.
  • JP Morgan Chase's HealthEquity position peaked at $180M in Q1 2022.
  • 498 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.